Cary Michael Looney

Cary Michael Looney is a Doctoral Student at Roche with a strong background in biomarker strategy development and implementation within clinical trials, particularly in non-oncology and immunology indications. Previously, Cary served as a Scientific Manager at Genentech, focusing on managing collaborations and developing biomarker strategies. Other roles include Senior Scientific Researcher at Genentech, where Cary facilitated biomarker strategy for immunology programs, Associate Scientist II at Gilead Sciences, and Senior Research Associate at Genentech, where Cary supported biomarker translational work. Early career experience includes a Research Associate position at the University of Washington, investigating microglial activation in neurodegeneration. Educational credentials include a PhD in Pharmacology from the University of Basel, an MS in Immunology from the University of Washington, and a BA in Molecular and Cellular Biology, Chemistry, and Mathematics from Bryn Mawr College.